The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions
Intestinal PermeabilityGastrointestinal IrritationMucositis
Interventions
DIETARY_SUPPLEMENT

Probiotic

Probiotics (beneficial microorganisms) VSL#3 is a probiotic formula containing a mixture of 9x10\^10 CFU/g Lactobacilli strains (Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus casei, and Lactobacillus bulgaricus), 8x10\^10 CFU/g Bifidum strains (Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis) and 20x10\^10 CFU/g Streptococcus thermophilus

Trial Locations (1)

2100 OE

Departmen of Oncology, Rigshospital, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Actial Farmaceutica S.r.l.

INDUSTRY

collaborator

Nutricia, Inc.

INDUSTRY

lead

University of Copenhagen

OTHER

NCT03704727 - The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy | Biotech Hunter | Biotech Hunter